International law firm Osborne Clarke has advised Uniphar plc on the acquisitions of UK-based brand commercialisation and pharmaceutical marketing agency, Events4Healthcare ("E4H"), and UK-based pharmaceutical distributor Devonshire Healthcare Services ("Devonshire").
The Osborne Clarke corporate team was led by partner Matthew Edwards with senior associate Will Carlyle and associate Laurence Nelson. Partner Mathew Oliver, senior associate Jonny Musty and associate Ben Doeh advised on tax.
E4H offers a wide range of digital and communications solutions to the pharmaceutical industry, including brand and strategy commercialisation, digital development, omnichannel delivery, engagement and data analysis. E4H will be integrated into the Uniphar's Commercial & Clinical Pharma division, enhancing Uniphar's value proposition of creating a truly differentiated omni-channel offering for pharmaceutical clients looking to commercialise their brands across Europe.
Devonshire has provided access to unlicensed and difficult to source medicines across the Middle East and North Africa ("MENA") region for 25 years to a broad variety of healthcare authorities, hospitals, overseas ministries of health and military agencies. Devonshire will be integrated into Uniphar's Product Access division, expanding its global access into key hospitals in the MENA region for the benefit of both its On Demand and Exclusive Access businesses. Devonshire will benefit from Uniphar's existing operational infrastructure and drive cross-selling opportunities between both businesses.
The combined revenue of the acquisitions, together with the acquisition of Irish-headquartered pharmacy services group, Navi Group ("Navi") which was announced on the same day. is €39m with the total increase in the number of colleagues joining Uniphar being 110 and expected annualised earnings accretion of mid-single digit.
Osborne Clarke’s Corporate team is a go-to practice for companies in both the life sciences & healthcare and tech, media & comms sectors. It works with clients ranging from global businesses to fast-growth start-ups and market challengers. The team advises at every stage of company development across all corporate issues, from equity and debt fundraisings to M&A, IPOs and JVs.
The firm is also the market leader in advising on evolving and disruptive technologies which are changing how businesses operate and compete, providing extraordinary, transformative opportunities. Visit our Digitalisation pages to find out more.